Centiva Capital’s Cidara Therapeutics CDTX Stock Holding History

Centiva Capital’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$6.63M	–	1732
2025 Q4	$6.63M	Buy	+30,000	New	+$4.85M	0.05%	216

Centiva Capital's CDTX Position: Q1 2026 in Review

Centiva Capital sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 25,000 shares — an estimated $5.52M sold.

Centiva Capital first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $5.52M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Centiva Capital reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Centiva Capital sold 25,000 Cidara Therapeutics shares in Q1 2026, an estimated $5.52M.
Centiva Capital first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Centiva Capital's Cidara Therapeutics position peaked at $5.52M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.